메뉴 건너뛰기




Volumn 11, Issue 1, 2010, Pages 1-9

Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy

Author keywords

Breast cancer; Estrogen receptor; Fractionated evaluation; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN;

EID: 75949126959     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B0900295     Document Type: Article
Times cited : (8)

References (30)
  • 1
    • 24744443547 scopus 로고    scopus 로고
    • Estrogen receptor-positive, progesterone receptor-negative breast cancer: Association with growth factor receptor expression and tamoxifen resistance
    • DOI 10.1093/jnci/dji249
    • G. Arpino H. Weiss A.V. Lee R. Schiff S. de Placido C.K. Osborne R.M. Elledge 2005 Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance J. Natl. Cancer Inst. 97 17 1254 1261 1:CAS:528:DC%2BD2MXpvFKjsrk%3D 16145046 (Pubitemid 41535366)
    • (2005) Journal of the National Cancer Institute , vol.97 , Issue.17 , pp. 1254-1261
    • Arpino, G.1    Weiss, H.2    Lee, A.V.3    Schiff, R.4    De Placido, S.5    Osborne, C.K.6    Elledge, R.M.7
  • 2
    • 45149107241 scopus 로고    scopus 로고
    • Estrogen- and progesterone-receptor status in ECOG 2197: Comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory
    • 10.1200/JCO.2007.13.6424 18487567
    • S.S. Badve F.L. Baehner R.P. Gray B.H. Childs T. Maddala M.L. Liu S.C. Rowley S. Shak E.A. Perez L.J. Shulman, et al. 2008 Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory J. Clin. Oncol. 26 15 2473 2481 10.1200/JCO.2007.13.6424 18487567
    • (2008) J. Clin. Oncol. , vol.26 , Issue.15 , pp. 2473-2481
    • Badve, S.S.1    Baehner, F.L.2    Gray, R.P.3    Childs, B.H.4    Maddala, T.5    Liu, M.L.6    Rowley, S.C.7    Shak, S.8    Perez, E.A.9    Shulman, L.J.10
  • 3
    • 4344683673 scopus 로고    scopus 로고
    • Tree-based model for breast cancer prognostication
    • DOI 10.1200/JCO.2004.11.141
    • M. Banerjee J. George E.Y. Song A. Roy W. Hryniuk 2004 Tree-based model for breast cancer prognostication J. Clin. Oncol. 22 13 2567 2575 10.1200/JCO.2004.11.141 15226324 (Pubitemid 41103743)
    • (2004) Journal of Clinical Oncology , vol.22 , Issue.13 , pp. 2567-2575
    • Banerjee, M.1    George, J.2    Song, E.Y.3    Roy, A.4    Hryniuk, W.5
  • 4
    • 0029804330 scopus 로고    scopus 로고
    • Immunohistochemical determination of oestrogen receptor: Comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients
    • 1:CAS:528:DyaK28XntVOis7o%3D 8912543
    • D.M. Barnes W.H. Harris P. Smith R.R. Millis R.D. Rubens 1996 Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients Br. J. Cancer 74 9 1445 1451 1:CAS:528:DyaK28XntVOis7o%3D 8912543
    • (1996) Br. J. Cancer , vol.74 , Issue.9 , pp. 1445-1451
    • Barnes, D.M.1    Harris, W.H.2    Smith, P.3    Millis, R.R.4    Rubens, R.D.5
  • 5
    • 9144226100 scopus 로고    scopus 로고
    • Prognostic and predictive factors in early-stage breast cancer
    • DOI 10.1634/theoncologist.9-6-606
    • M. Cianfrocca L.J. Goldstein 2004 Prognostic and predictive factors in early-stage breast cancer Oncologist 9 6 606 616 10.1634/theoncologist.9-6-606 15561805 (Pubitemid 39546402)
    • (2004) Oncologist , vol.9 , Issue.6 , pp. 606-616
    • Cianfrocca, M.1    Goldstein, L.J.2
  • 6
    • 11244272987 scopus 로고    scopus 로고
    • Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: An analysis of 825 cases
    • 10.1309/HCF035N9WK40ETJ0 15762275
    • L.C. Collins M.L. Botero S.J. Schnitt 2005 Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases Am. J. Clin. Pathol. 123 1 16 20 10.1309/HCF035N9WK40ETJ0 15762275
    • (2005) Am. J. Clin. Pathol. , vol.123 , Issue.1 , pp. 16-20
    • Collins, L.C.1    Botero, M.L.2    Schnitt, S.J.3
  • 7
    • 19344364880 scopus 로고    scopus 로고
    • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
    • DOI 10.1016/S0140-6736(05)66544-0, PII S0140673605665440
    • EBCTCG 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 9472 1687 1717 10.1016/S0140-6736(05)66544-0 (Pubitemid 40719106)
    • (2005) Lancet , vol.365 , Issue.9472 , pp. 1687-1717
  • 8
    • 0034688931 scopus 로고    scopus 로고
    • Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immunohistochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group Study
    • 10.1002/(SICI)1097-0215(20000320)89:2<111::AID-IJC2>3.0.CO;2-W 1:CAS:528:DC%2BD3cXislehsrw%3D 10754487
    • R.M. Elledge S. Green R. Pugh D.C. Allred G.M. Clark J. Hill P. Ravdin S. Martino C.K. Osborne 2000 Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immunohistochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study Int. J. Cancer 89 2 111 117 10.1002/(SICI)1097-0215(20000320)89:2<111::AID-IJC2>3.0.CO;2-W 1:CAS:528:DC%2BD3cXislehsrw%3D 10754487
    • (2000) Int. J. Cancer , vol.89 , Issue.2 , pp. 111-117
    • Elledge, R.M.1    Green, S.2    Pugh, R.3    Allred, D.C.4    Clark, G.M.5    Hill, J.6    Ravdin, P.7    Martino, S.8    Osborne, C.K.9
  • 9
    • 0035884620 scopus 로고    scopus 로고
    • Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: Evidence from a phase III randomized trial
    • 1:CAS:528:DC%2BD3MXnsVKqsbo%3D 11559718
    • M.J. Ellis A. Coop B. Singh L. Mauriac A. Llombert-Cussac F. Janicke W.R. Miller D.B. Evans M. Dugan C. Brady E. Quebe-Fehling M. Borgs 2001 Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial J. Clin. Oncol. 19 18 3808 3816 1:CAS:528:DC%2BD3MXnsVKqsbo%3D 11559718
    • (2001) J. Clin. Oncol. , vol.19 , Issue.18 , pp. 3808-3816
    • Ellis, M.J.1    Coop, A.2    Singh, B.3    Mauriac, L.4    Llombert-Cussac, A.5    Janicke, F.6    Miller, W.R.7    Evans, D.B.8    Dugan, M.9    Brady, C.10    Quebe-Fehling, E.11    Borgs, M.12
  • 10
    • 0026072872 scopus 로고
    • Pathological prognostic factors in breast cancer. I. the value of histological grade in breast cancer: Experience from a large study with long-term follow-up
    • 10.1111/j.1365-2559.1991.tb00229.x 1:STN:280:DyaK38%2FpvVSltw%3D%3D 1757079
    • C.W. Elston I.O. Ellis 1991 Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 5 403 410 10.1111/j.1365-2559.1991.tb00229.x 1:STN:280:DyaK38%2FpvVSltw%3D%3D 1757079
    • (1991) Histopathology , vol.19 , Issue.5 , pp. 403-410
    • Elston, C.W.1    Ellis, I.O.2
  • 11
    • 0004259315 scopus 로고    scopus 로고
    • Churchill Livingston Edinburgh
    • Elston, C.W., Ellis, I.O., 1998. The Breast. Churchill Livingston, Edinburgh, p.673.
    • (1998) The Breast , pp. 673
    • Elston, C.W.1    Ellis, I.O.2
  • 12
    • 2342552056 scopus 로고    scopus 로고
    • Prognostic molecular markers in early breast cancer
    • DOI 10.1186/bcr777
    • F.J. Esteva G.N. Hortobagyi 2004 Prognostic molecular markers in early breast cancer Breast Cancer Res. 6 3 109 118 10.1186/bcr777 1:CAS:528: DC%2BD2cXotVSlu7k%3D 15084231 (Pubitemid 38607664)
    • (2004) Breast Cancer Research , vol.6 , Issue.3 , pp. 109-118
    • Esteva, F.J.1    Hortobagyi, G.N.2
  • 13
    • 0034849122 scopus 로고    scopus 로고
    • Comparison of enzyme immunoassay and immunohistochemical measurements of estrogen and progesterone receptors in breast cancer patients
    • DOI 10.1097/00022744-200109000-00012
    • M. Ferrero-Pous M. Trassard V. Le Doussal K. Hacene M. Tubiana-Hulin F. Spyratos 2001 Comparison of enzyme immunoassay and immunohistochemical measurements of estrogen and progesterone receptors in breast cancer patients Appl. Immunohistochem. Mol. Morphol. 9 3 267 275 10.1097/00022744-200109000- 00012 1:CAS:528:DC%2BD3MXmslyit7c%3D 11556756 (Pubitemid 32783051)
    • (2001) Applied Immunohistochemistry and Molecular Morphology , vol.9 , Issue.3 , pp. 267-275
    • Ferrero-Pous, M.1    Trassard, M.2    Le Doussal, V.3    Hacene, K.4    Tubiana-Hulin, M.5    Spyratos, F.6
  • 14
    • 0032896905 scopus 로고    scopus 로고
    • Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer
    • 1:STN:280:DyaK1M3msFOjsA%3D%3D 10334533
    • J.M. Harvey G.M. Clark C.K. Osborne D.C. Allred 1999 Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer J. Clin. Oncol. 17 5 1474 1481 1:STN:280:DyaK1M3msFOjsA%3D%3D 10334533
    • (1999) J. Clin. Oncol. , vol.17 , Issue.5 , pp. 1474-1481
    • Harvey, J.M.1    Clark, G.M.2    Osborne, C.K.3    Allred, D.C.4
  • 15
    • 35848938197 scopus 로고    scopus 로고
    • Assessment of hormone receptor status in breast cancer
    • DOI 10.1111/j.1440-1827.2007.02174.x
    • R. Horii F. Akiyama Y. Ito T. Iwase 2007 Assessment of hormone receptor status in breast cancer Pathol. Int. 57 12 784 790 10.1111/j.1440-1827.2007. 02174.x 1:CAS:528:DC%2BD1cXjsVWqtA%3D%3D 17988279 (Pubitemid 350060601)
    • (2007) Pathology International , vol.57 , Issue.12 , pp. 784-790
    • Horii, R.1    Akiyama, F.2    Ito, Y.3    Iwase, T.4
  • 16
    • 0029804489 scopus 로고    scopus 로고
    • Immunohistochemical assay for oestrogen receptors in paraffin wax sections of breast carcinoma using a new monoclonal antibody
    • DOI 10.1002/(SICI)1096-9896(199610)180:2<223::AID-PATH635>3.0.CO;2- H
    • A. Huang N.M. Pettigrew P.H. Watson 1996 Immunohistochemical assay for oestrogen receptors in paraffin wax sections of breast carcinoma using a new monoclonal antibody J. Pathol. 180 2 223 237 10.1002/(SICI)1096-9896(199610)180: 2<223::AID-PATH635>3.0.CO;2-H 1:CAS:528:DyaK28XntFCltLo%3D 8976884 (Pubitemid 26370191)
    • (1996) Journal of Pathology , vol.180 , Issue.2 , pp. 223-227
    • Huang, A.1    Pettigrew, N.M.2    Watson, P.H.3
  • 17
    • 48749117418 scopus 로고    scopus 로고
    • The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers
    • 10.1634/theoncologist.2007-0246 1:CAS:528:DC%2BD1cXhtVCqtbvI 18614591
    • C.S. Huang S.H. Kuo H.C. Lien S.Y. Yang S.L. You C.Y. Shen C.H. Lin Y.S. Lu K.J. Chang 2008 The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers Oncologist 13 7 751 760 10.1634/theoncologist.2007-0246 1:CAS:528: DC%2BD1cXhtVCqtbvI 18614591
    • (2008) Oncologist , vol.13 , Issue.7 , pp. 751-760
    • Huang, C.S.1    Kuo, S.H.2    Lien, H.C.3    Yang, S.Y.4    You, S.L.5    Shen, C.Y.6    Lin, C.H.7    Lu, Y.S.8    Chang, K.J.9
  • 19
    • 72449138716 scopus 로고    scopus 로고
    • Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients
    • 10.1007/s10549-009-0318-0 1:CAS:528:DC%2BD1MXhsFaqtrrI 19205877
    • S. Liu S.K. Chia E. Mehl S. Leung A. Rajput M.C. Cheang T.O. Nielsen 2010 Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients Breast Cancer Res. Treat 119 1 53 61 10.1007/s10549-009-0318-0 1:CAS:528: DC%2BD1MXhsFaqtrrI 19205877
    • (2010) Breast Cancer Res. Treat , vol.119 , Issue.1 , pp. 53-61
    • Liu, S.1    Chia, S.K.2    Mehl, E.3    Leung, S.4    Rajput, A.5    Cheang, M.C.6    Nielsen, T.O.7
  • 20
    • 0034036437 scopus 로고    scopus 로고
    • Accuracy of cause-of-death coding in Taiwan: Types of miscoding and effects on mortality statistics
    • 10.1093/ije/29.2.336 1:STN:280:DC%2BD3c3nsVygtw%3D%3D 10817134
    • T.H. Lu M.C. Lee M.C. Chou 2000 Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics Int. J. Epidemiol. 29 2 336 343 10.1093/ije/29.2.336 1:STN:280:DC%2BD3c3nsVygtw%3D%3D 10817134
    • (2000) Int. J. Epidemiol. , vol.29 , Issue.2 , pp. 336-343
    • Lu, T.H.1    Lee, M.C.2    Chou, M.C.3
  • 21
    • 10344263365 scopus 로고    scopus 로고
    • Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: A validation study
    • DOI 10.1038/modpathol.3800229
    • S.K. Mohsin H. Weiss T. Havighurst G.M. Clark M. Berardo D. Roanhle T.V. To Z. Qian R.R. Love D.C. Allred 2004 Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study Mod. Pathol. 17 12 1545 1554 10.1038/modpathol.3800229 1:CAS:528: DC%2BD2cXhtFGmsL3O 15272277 (Pubitemid 39627082)
    • (2004) Modern Pathology , vol.17 , Issue.12 , pp. 1545-1554
    • Mohsin, S.K.1    Weiss, H.2    Havighurst, T.3    Clark, G.M.4    Berardo, M.5    Roanh, L.D.6    To, T.V.7    Zho, Q.8    Love, R.R.9    Allred, D.C.10
  • 22
    • 11244253900 scopus 로고    scopus 로고
    • Immunohistochemistry of estrogen and progesterone receptors reconsidered: Experience with 5993 breast cancers
    • 10.1309/4WV79N2GHJ3X1841 15762276
    • M. Nadji C. Gomez-Fernandez P. Ganjei-Azar A.R. Morales 2005 Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5993 breast cancers Am. J. Clin. Pathol. 123 1 21 27 10.1309/4WV79N2GHJ3X1841 15762276
    • (2005) Am. J. Clin. Pathol. , vol.123 , Issue.1 , pp. 21-27
    • Nadji, M.1    Gomez-Fernandez, C.2    Ganjei-Azar, P.3    Morales, A.R.4
  • 23
    • 0029950536 scopus 로고    scopus 로고
    • Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Spγ in frozen sections or cytosol-based ligand-binding assays
    • DOI 10.1002/(SICI)1097-0142(19960615)77:12<2514::AID-CNCR14>3.0. CO;2-V
    • L.P. Pertschuk J.G. Feldman Y.D. Kim L. Braithwaite F. Schneider A.S. Braverman C. Axiotis 1996 Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays Cancer 77 12 2514 2519 10.1002/(SICI)1097-0142(19960615)77:12<2514:: AID-CNCR14>3.0.CO;2-V 1:CAS:528:DyaK28XjvVyrurw%3D 8640700 (Pubitemid 26169148)
    • (1996) Cancer , vol.77 , Issue.12 , pp. 2514-2519
    • Pertschuk, L.P.1    Feldman, J.G.2    Kim, Y.-D.3    Braithwaite, L.4    Schneider, F.5    Braverman, A.S.6    Axiotis, C.7
  • 24
    • 0026747130 scopus 로고
    • Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: Results of a prospective Southwest Oncology Group study
    • 1:STN:280:DyaK38zktFWntg%3D%3D 1634918
    • P.M. Ravdin S. Green T.M. Dorr W.L. McGuire C. Fabian R.P. Pugh R.D. Carter S.E. Rivkin J.R. Borst R.J. Belt B. Metch C.K. Osborne 1992 Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study J. Clin. Oncol. 10 8 1284 1291 1:STN:280:DyaK38zktFWntg%3D%3D 1634918
    • (1992) J. Clin. Oncol. , vol.10 , Issue.8 , pp. 1284-1291
    • Ravdin, P.M.1    Green, S.2    Dorr, T.M.3    McGuire, W.L.4    Fabian, C.5    Pugh, R.P.6    Carter, R.D.7    Rivkin, S.E.8    Borst, J.R.9    Belt, R.J.10    Metch, B.11    Osborne, C.K.12
  • 25
    • 33750576185 scopus 로고    scopus 로고
    • Re-evaluating adjuvant breast cancer trials: Assessing hormone receptor status by immunohistochemical versus extraction assays
    • 1:CAS:528:DC%2BD28XhtFyqt7%2FL 17077359
    • M.M. Regan G. Viale M.G. Mastropasqua E. Maiorano R. Golouh A. Carbone B. Brown M. Suurkula G. Langman L. Mazzucchelli, et al. 2006 Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays J. Natl. Cancer Inst. 98 21 1571 1581 1:CAS:528:DC%2BD28XhtFyqt7%2FL 17077359
    • (2006) J. Natl. Cancer Inst. , vol.98 , Issue.21 , pp. 1571-1581
    • Regan, M.M.1    Viale, G.2    Mastropasqua, M.G.3    Maiorano, E.4    Golouh, R.5    Carbone, A.6    Brown, B.7    Suurkula, M.8    Langman, G.9    Mazzucchelli, L.10
  • 26
    • 0023019294 scopus 로고
    • Estrogen receptor analysis on biopsies and fine-needle aspirates from human breast carcinoma. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies
    • 1:CAS:528:DyaL2sXot1CjsA%3D%3D 3541638
    • A. Reiner J. Spona G. Reiner M. Schemper R. Kolb W. Kwasny R. Fugger R. Jakesz J.H. Holzner 1986 Estrogen receptor analysis on biopsies and fine-needle aspirates from human breast carcinoma. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies Am. J. Pathol. 125 3 443 449 1:CAS:528:DyaL2sXot1CjsA%3D%3D 3541638
    • (1986) Am. J. Pathol. , vol.125 , Issue.3 , pp. 443-449
    • Reiner, A.1    Spona, J.2    Reiner, G.3    Schemper, M.4    Kolb, R.5    Kwasny, W.6    Fugger, R.7    Jakesz, R.8    Holzner, J.H.9
  • 27
    • 33748071468 scopus 로고    scopus 로고
    • High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients
    • DOI 10.1158/1078-0432.CCR-06-0248
    • M. Stendahl L. Ryden B. Nordenskjold P.E. Jonsson G. Landberg K. Jirstrom 2006 High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients Clin. Cancer Res. 12 15 4614 4618 10.1158/1078-0432.CCR-06-0248 1:CAS:528:DC%2BD28XnvVGks70%3D 16899609 (Pubitemid 44297812)
    • (2006) Clinical Cancer Research , vol.12 , Issue.15 , pp. 4614-4618
    • Stendahl, M.1    Ryden, L.2    Nordenskjold, B.3    Jonsson, P.E.4    Landberg, G.5    Jirstrom, K.6
  • 28
    • 0027293310 scopus 로고
    • Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors
    • 10.1097/00000658-199307000-00004 1:STN:280:DyaK3szhvFeitw%3D%3D 8328824
    • M. Stierer H. Rosen R. Weber H. Hanak J. Spona H. Tuchler 1993 Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors Ann. Surg. 218 1 13 21 10.1097/00000658-199307000-00004 1:STN:280:DyaK3szhvFeitw%3D%3D 8328824
    • (1993) Ann. Surg. , vol.218 , Issue.1 , pp. 13-21
    • Stierer, M.1    Rosen, H.2    Weber, R.3    Hanak, H.4    Spona, J.5    Tuchler, H.6
  • 30
    • 41149114592 scopus 로고    scopus 로고
    • Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: Predictive value of centrally reviewed expression of estrogen and progesterone receptors-International Breast Cancer Study Group
    • 10.1200/JCO.2007.10.6393 18349391
    • G. Viale M.M. Regan E. Maiorano M.G. Mastropasqua R. Golouh T. Perin R.W. Brown A. Kovacs K. Pillay C. Ohlschlegel, et al. 2008 Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors-International Breast Cancer Study Group J. Clin. Oncol. 26 9 1404 1410 10.1200/JCO.2007.10.6393 18349391
    • (2008) J. Clin. Oncol. , vol.26 , Issue.9 , pp. 1404-1410
    • Viale, G.1    Regan, M.M.2    Maiorano, E.3    Mastropasqua, M.G.4    Golouh, R.5    Perin, T.6    Brown, R.W.7    Kovacs, A.8    Pillay, K.9    Ohlschlegel, C.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.